Moderna, Inc. (BIT:1MRNA)

Italy flag Italy · Delayed Price · Currency is EUR
23.16
+1.15 (5.23%)
At close: Dec 5, 2025
-42.39%
Market Cap 9.30B
Revenue (ttm) 1.90B
Net Income (ttm) -2.66B
Shares Out n/a
EPS (ttm) -6.86
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 51,386
Average Volume 16,998
Open 21.90
Previous Close 22.01
Day's Range 21.82 - 23.26
52-Week Range 19.38 - 49.34
Beta n/a
RSI 59.88
Earnings Date Feb 20, 2026

About Moderna

Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company’s respiratory vaccines include spikevax, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public health vaccines consist of Zika, Nipah, and Mpox vaccines; and bacterial diseases vaccines, su... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2010
Employees 5,800
Stock Exchange Borsa Italiana
Ticker Symbol 1MRNA
Full Company Profile

Financial Performance

In 2024, Moderna's revenue was $3.24 billion, a decrease of -52.75% compared to the previous year's $6.85 billion. Losses were -$3.56 billion, -24.46% less than in 2023.

Financial numbers in USD Financial Statements

News

There is no news available yet.